Recent corporate updates for Turn Therapeutics focus on the clinical expansion and commercial scaling of its proprietary antimicrobial and wound care polymer technologies. The company continues to advance its therapeutic pipeline through strategic healthcare partnerships, institutional research validations, and regulatory filings designed to broaden the market reach of its innovative infection-control and soft-tissue management products across clinical and residential care facilities globally.